Acute Myeloid Leukemia Clinical Trials in Basel
3 recruitingBasel, Switzerland
Showing 1–3 of 3 trials
Recruiting
Phase 3
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Adult Acute Myeloid Leukemia
Priothera SAS366 enrolled108 locationsNCT05429632
Recruiting
Phase 1Phase 2
Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS
Acute Myeloid LeukemiaMyelodysplastic Syndromes
University Hospital, Basel, Switzerland10 enrolled1 locationNCT03300492
Recruiting
Phase 3
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
Acute Myeloid Leukemia
Stichting Hemato-Oncologie voor Volwassenen Nederland227 enrolled119 locationsNCT07075016